Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a

T cells become licensed in the lung to enter the central nervous system

(2012) Francesca Odoardi et al.   NATURE

Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis

(2011) Anna Karin Hedström et al.   BRAIN

Persistency of neutralizing antibodies depends on titer and interferon-beta preparation

(2011) Harald Hegen et al.   Multiple Sclerosis Journal

Smoking: effects on multiple sclerosis susceptibility and disease progression

(2011) Dean M. Wingerchuk   Therapeutic Advances in Neurological Disorders

Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta

(2010) Armando Sena et al.   JOURNAL OF NEUROLOGY

Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis

(2009) Hiba Mahdi et al.   NATURE GENETICS

Absence of MxA induction by interferon   in patients with MS reflects complete loss of bioactivity

(2009) D. Hesse et al.   NEUROLOGY

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

(2009) A. K. Hedstrom et al.   NEUROLOGY

Lung Myeloid Dendritic Cells Coordinately Induce TH1 and TH17 Responses in Human Emphysema

(2009) M. Shan et al.   Science Translational Medicine

HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis

(2008) Steve Hoffmann et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells

(2008) D Makrygiannakis et al.   ANNALS OF THE RHEUMATIC DISEASES